AstraZeneca shared the topline result from the placebo-controlled ... before AZ and its partner Merck were able to cross the ...

AstraZeneca raises its fiscal 2024 guidance for the second consecutive quarter. This upgrade comes despite ongoing legal ...

AstraZeneca, Daiichi Sankyo seek US FDA’s accelerated approval for datopotamab deruxtecan to treat advanced EGFR-mutated NSCLC ...

Despite China’s investigations into insurance fraud, allegedly illegal importation of unapproved drugs and improper ...

Scientists who want a say in the future of their inventions are once again moving from academia to the C-suite ...

AstraZeneca has upgraded its revenue and earnings guidance for this year. Total revenues and core earnings per share rose 21% ...

Pascal Soriot, CEO of AstraZeneca, said the growth in total revenue and core earnings per share reflected the "increasing ...

Daiichi Sankyo collaboration AstraZeneca and Daiichi Sankyo entered into a global collaboration to jointly develop and commercialise Enhertu (trastuzumab deruxtecan) in March 2019 and datopotamab ...

The two parties, together with AstraZeneca, will cooperate on scientific research ... Health Engineering was established ...

The FTSE 100 index is seen opening eight points higher at 8034, having fallen 1.2% to a three-month low in yesterday’s ...

The 38-year-old Hollywood star and the 34-year-old musician have been a couple since 2020. They were engaged in 2022 but called off the engagement earlier this year although they have since continued ...

Daiichi Sankyo & AstraZeneca’s Enhertu receives 2024 Prix Galien USA Award for Best Biotechnology Product: Tokyo Monday, November 11, 2024, 09:00 Hrs [IST] Daiichi Sankyo and As ...